The company, formerly known as Hebei Changshan Biochemical Pharmaceutical Co., Ltd., was founded on September 28, 2000. Since its establishment, the company has always been committed to the R&D, production and sales of heparin series products. After years of development, it has gradually established a leading position in the domestic field of heparin raw materials and heparin preparations. Since its establishment, the company has mainly developed, produced and sold drugs to treat cardiovascular and cerebrovascular diseases. The main heparin products are: heparin sodium crude products, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and low molecular weight heparin calcium injections, enoxaparin sodium raw materials and enoxaparin sodium injections, nadroparin calcium raw materials and nadroparin calcium injections, heparin sodium raw materials, and heparin sodium injections. Corporate honors: Selected by China Shuangchuang as a model enterprise for entrepreneurship and innovation in China, Wanmaishu brand low molecular weight heparin calcium injection was recognized by the Shijiazhuang Municipal People's Government as the top ten industrial brand products in Shijiazhuang City in 2017.
No Data